Back to 
Morgan Stanley
Morgan Stanley
ERNA
4 quarters
Position history for Morgan Stanley's holdings in Ernexa Therapeutics Inc.
No. Morgan Stanley exited its ERNA (Ernexa Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 30 shares worth $36. Morgan Stanley first reported ERNA in Q2 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1,019
Total Shares Change
-554
Quarter-by-Quarter History
Other major holders of ERNA: Corient Private Wealth LP, Geode Capital Management, LLC, Vanguard Group Inc.